Log in
Enquire now
‌

Low-Load Blood Flow Restriction on Patients With Multiple Sclerosis

OverviewStructured DataIssuesContributors

Contents

clinicaltrials.gov/study/NCT05177952
Is a
‌
Clinical study
0

Clinical Study attributes

NCT Number
NCT051779520
Health Conditions in Trial
Multiple sclerosis
Multiple sclerosis
0
Trial Recruitment Size
300
Trial Sponsor
University of Central Florida
University of Central Florida
0
Trial Collaborator
AdventHealth
AdventHealth
0
Clinical Trial Start Date
January 1, 2022
0
Primary Completion Date
December 31, 2022
0
Study Completion Date
December 31, 2022
0
Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Other0
Intervention Name
Standard of Care0
Blood Flow Restriction0
Interventional Trial Phase
Not Applicable0
Participating Facility
University of Central Florida
University of Central Florida
0
Official Name
The Chronic Effects of Low-Load Blood Flow Restriction or Standard of Care Resistance Exercise on Muscle and Neuromuscular Function in Patients With Multiple Sclerosis0
Last Updated
January 5, 2022
0
Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
None (Open Label)0
Study summary

This research is being done to compare the current standard of care for strength training for patients with Multiple Sclerosis to lightweight resistance training with blood flow restriction.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like Low-Load Blood Flow Restriction on Patients With Multiple Sclerosis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.